Brookwood Investment Group LLC Makes New $1.03 Million Investment in Doximity, Inc. $DOCS

Brookwood Investment Group LLC purchased a new position in Doximity, Inc. (NASDAQ:DOCS) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 16,808 shares of the company’s stock, valued at approximately $1,031,000.

Several other hedge funds have also recently added to or reduced their stakes in the business. GAMMA Investing LLC grew its position in Doximity by 5.9% in the second quarter. GAMMA Investing LLC now owns 2,981 shares of the company’s stock worth $183,000 after buying an additional 165 shares during the last quarter. Amalgamated Bank grew its position in Doximity by 0.3% during the 1st quarter. Amalgamated Bank now owns 60,928 shares of the company’s stock worth $3,536,000 after purchasing an additional 186 shares in the last quarter. Louisiana State Employees Retirement System grew its position in Doximity by 0.5% during the 2nd quarter. Louisiana State Employees Retirement System now owns 37,600 shares of the company’s stock worth $2,306,000 after purchasing an additional 200 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Doximity by 0.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company’s stock worth $2,262,000 after purchasing an additional 210 shares in the last quarter. Finally, Greenleaf Trust grew its position in Doximity by 5.4% during the 1st quarter. Greenleaf Trust now owns 4,492 shares of the company’s stock worth $261,000 after purchasing an additional 230 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Stock Up 1.0%

Shares of NASDAQ:DOCS opened at $66.93 on Monday. The firm has a fifty day moving average of $69.60 and a two-hundred day moving average of $61.85. The firm has a market capitalization of $12.54 billion, a P/E ratio of 66.93, a price-to-earnings-growth ratio of 4.10 and a beta of 1.38. Doximity, Inc. has a 12-month low of $40.87 and a 12-month high of $85.21.

Doximity (NASDAQ:DOCS) last issued its earnings results on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The firm’s revenue for the quarter was up 15.2% on a year-over-year basis. During the same quarter last year, the company posted $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Equities research analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Insider Activity at Doximity

In related news, Director Regina M. Benjamin sold 5,000 shares of Doximity stock in a transaction on Friday, October 10th. The shares were sold at an average price of $70.84, for a total value of $354,200.00. Following the completion of the sale, the director owned 19,839 shares of the company’s stock, valued at approximately $1,405,394.76. The trade was a 20.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction on Wednesday, September 24th. The shares were sold at an average price of $75.00, for a total transaction of $1,500,000.00. Following the completion of the sale, the director directly owned 3,221 shares of the company’s stock, valued at approximately $241,575. The trade was a 86.13% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 37,000 shares of company stock valued at $2,635,880. Insiders own 31.30% of the company’s stock.

Analyst Ratings Changes

DOCS has been the topic of several research analyst reports. Truist Financial lifted their price objective on shares of Doximity from $52.00 to $61.00 and gave the stock a “hold” rating in a research report on Thursday, July 17th. The Goldman Sachs Group set a $64.00 price objective on shares of Doximity and gave the stock a “sell” rating in a research report on Wednesday, October 1st. Canaccord Genuity Group lifted their price objective on shares of Doximity from $59.00 to $67.00 and gave the stock a “hold” rating in a research report on Thursday, September 18th. Raymond James Financial set a $75.00 price objective on shares of Doximity in a research report on Wednesday, September 10th. Finally, Robert W. Baird lifted their price objective on shares of Doximity from $75.00 to $80.00 and gave the stock an “outperform” rating in a research report on Thursday, September 11th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $69.37.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.